UK clinical trial into puberty blockers on hold after medicines regulator steps in
Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14 A clinical trial into puberty blockers for children has been paused after the medicines regulator warned it should have a minimum age limit of 14 because of the “unquantified risk” of “long-term biological harms”.Discussions between the Medicines and Healthcare products Regulatory Agency (MHRA) and the trial spo…
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
